Additional information | |
|---|---|
| Department | IMMUNOLOGY |
| Speciality Name | CA 15.3* |
| Test type | Pathology |
| Also known as | CA 15 3 |
| Report | 24 Hours |
| Availability | All centre |
No Patient preparation needed.
The CA 15.3 test is a blood test that is primarily used to monitor the breast cancer treatment effectiveness and detect recurrence and track the advanced or metastatic disease. It measures the protein released by the tumor cells. While not used for the general screening and high levels indicate potential tumor growth or spread. This test is primarily monitored progress in patients already diagnosed with breast cancer particularly metastatic rather than to detect early stage disease. This test decreasing the levels often indicates that treatment is working while increasing levels may suggest tumor growth or recurrence. It has low sensitivity for the early stage breast cancer and can be elevated in non cancerous conditions like liver disease or benign breast disease. This test provides valuable information about disease progression. It supports clinical decision-making. It helps in long-term patient management, this test is cost-effective compared to imaging tests.
CA 15.3 primarily monitors progress in patients already diagnosed with breast cancer particularly metastatic rather than to detect early stage disease. This test decreasing the levels often indicates that treatment is working while increasing levels may suggest tumor growth or recurrence. There are various diagnostic centres to book online tests for CA 15.3 in Delhi but patients can opt for City Imaging and Clinical Labs for quality results and affordable price. The testing centre provides high quality results with advanced machines and experienced doctors.
The CA 15.3 test is performed for several important clinical purposes.
Common purposes include:
These purposes make the test useful in cancer management.
The test offers several advantages in clinical practice.
Key benefits include:
These benefits highlight its importance in oncology.
Despite its usefulness, the test has certain limitations.
Some limitations include:
| S. No | Condition | Description |
| 1 | Breast Cancer | Most common cause of elevated levels |
| 2 | Lung Cancer | May cause increased CA 15.3 |
| 3 | Ovarian Cancer | Associated with elevated marker |
| S. No | Cause | Explanation |
| 1 | Known Breast Cancer | Monitoring disease progression |
| 2 | Treatment Follow-Up | Checking response to therapy |
| 3 | Suspected Recurrence | Detecting cancer return |
CA 15.3 test near me in Delhi is City Imaging and Clinical Labs, which provides best quality tests at affordable rates. The testing centre for CA 15.3 is accredited by Government agencies and has vast experience in the diagnosis field of CA 15.3 with well experienced doctors.
There are various diagnostic centres to book online tests for CA 15.3 in Delhi but patients can opt for City Imaging and Clinical Labs for quality results and affordable price. The testing centre provides high quality results with advanced machines and experienced doctors. You can book the test by visiting the website and it can be done in easy steps or call the customer care numbers for online booking.
Patients can choose City Imaging and Clinical Labs for CA 15.3 test in Delhi because this centre has advanced equipment with experienced doctors. The testing lab is accredited from NABL and NABH, which provides quality results at affordable prices. The diagnostic centre is having good patient service with helpline numbers for round the clock availability.
The patient can book the CA 15.3 test online at City Imaging and the Clinical Labs by visiting the website and book the appointment online. There are also the customer care numbers in the website where the patient can dial and book the CA 15.3 detailed instructions related to the test.
The price of CA 15.3 in Delhi may range from INR 900 to INR 2000. The price may vary depending on the various factors like location of diagnostic centre.
CA 15.3 test is primarily used to monitor the breast cancer treatment effectiveness and detect recurrence and track advanced or metastatic disease. It measures the protein released by the tumor cells. While not used for the general screening and high levels indicate potential tumor growth or spread. This test primarily monitors progress in patients already diagnosed with breast cancer particularly metastatic rather than to detect early stage disease. Patients can choose City Imaging and Clinical Labs for CA 15.3 test in Delhi because this centre has advanced equipment with experienced doctors.
It is a blood test that is used to measure the tumour marker associated with breast cancer.
It is done to monitor the cancer treatment and detect the recurrence.
No, it is not used alone for diagnosis.
No, it involves a simple blood draw.
The sample collection takes only a few minutes.
Yes, some non-cancer conditions can also increase its levels.
It may be repeated regularly to monitor disease progress.
Results are usually available after laboratory analysis.
Related tests